News Crossject

Equities

Real-time Euronext Paris Other stock markets 10:00:33 2024-05-06 am EDT			5-day change	1st Jan Change
2.18 ^EUR	-2.24%		+5.57%	-56.14%

May. 03	Crossject: praised for extended agreement on Zepizure	CF
May. 02	Crossject Signs A Geographic Extension of ZEPIZURE Commercialization Agreement in Europe	CI

Crossject: praised for extended agreement on Zepizure	May. 03	CF
Crossject signs a geographic extension of ZEPIZURE® commercialization agreement in Europe	May. 02	GL
Crossject Signs A Geographic Extension of ZEPIZURE Commercialization Agreement in Europe	May. 02	CI
CROSSJECT : We welcome the securing of the group’s financial needs	May. 02	AL
Crossject reports audited financial results for 2023	Apr. 25	GL
CROSSJECT : Patience is a virtue… hopefully	Apr. 03	AL
Crossject trading on Euronext to resume as usual on Wednesday April 3	Apr. 02	GL
Crossject advances in its U.S. Strategy and reports Financial Results for 2023	Apr. 02	GL
Crossject Société Anonyme Reports Earnings Results for the Full Year Ended December 31, 2023	Apr. 02	CI
Crossject gender equality score reaches 96/100 in 2024	Mar. 08	GL
Crossject gender equality score reaches 96/100 in 2024	Mar. 08	AQ
CROSSJECT : Invest Securities slightly reduces its target	Feb. 28	CF
CROSSJECT : Securing the financing needs	Feb. 28	AL
Crossject: share price falls after convertible bond issue	Feb. 27	CF
Crossject obtains a financing up to €12 million, in two tranches	Feb. 27	GL
Crossject obtains a financing up to €12 million, in two tranches	Feb. 27	AQ
Crossject Société Anonyme announced that it expects to receive ?12 million in funding	Feb. 25	CI
CROSSJECT : No news is not always good news...	Feb. 08	AL
Crossject: strategy advances, but visibility worries	Feb. 07	CF
Crossject provides strategic update on priorities for 2024	Feb. 06	GL

No results for this search